# TPG Group Holdings (SBS) Advisors, Inc.

> Institutional holdings reported to the SEC as of Q3 2021 on Form 13F. CIK 1495741. Source: https://holderbook.com/funds/1495741-tpg-group-holdings-sbs-advisors-inc/

- Reported value: $10.1B
- Positions: 52
- Weight of the ten largest: 73.4%
- Filed: 2022-02-25

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| LIFESTANCE HEALTH GROUP INC | [LFST](https://holderbook.com/stocks/LFST/) | $2.5B | 175,284,635 | 25.2% | 2 |
| MCAFEE CORP | [MCFE](https://holderbook.com/stocks/MCFE/) | $1.3B | 60,172,786 | 13.2% | 4 |
| CUSHMAN WAKEFIELD PLC | [CWK](https://holderbook.com/stocks/CWK/) | $702.6M | 37,753,672 | 7.0% | 9 |
| PROGYNY INC | [PGNY](https://holderbook.com/stocks/PGNY/) | $560.0M | 10,000,000 | 5.6% | 8 |
| ALLOGENE THERAPEUTICS INC | [ALLO](https://holderbook.com/stocks/ALLO/) | $481.0M | 18,716,306 | 4.8% | 12 |
| CONVEY HEALTH SOLUTIONS HLDG | [CNVY](https://holderbook.com/stocks/CNVY/) | $459.5M | 54,699,513 | 4.6% | 2 |
| ELEVANCE HEALTH INC FORMERLY | [ELV](https://holderbook.com/stocks/ELV/) | $398.1M | 1,067,795 | 3.9% | 10 |
| FIDELITY NATL INFORMATION SV | [FIS](https://holderbook.com/stocks/FIS/) | $354.8M | 2,916,245 | 3.5% | 9 |
| THOMSON REUTERS CORP. | [TRIXXXX](https://holderbook.com/stocks/TRIXXXX/) | $308.4M | 2,791,010 | 3.1% | 5 |
| LIBERTY MEDIA CORP DEL | [FWONKXXXX](https://holderbook.com/stocks/FWONKXXXX/) | $266.0M | 5,174,220 | 2.6% | 5 |
| ANAPLAN INC | [PLAN](https://holderbook.com/stocks/PLAN/) | $236.3M | 3,881,198 | 2.3% | 3 |
| C3 AI INC | [AI](https://holderbook.com/stocks/AI/) | $211.3M | 4,560,322 | 2.1% | 4 |
| COMCAST CORP NEW | [CMCSA](https://holderbook.com/stocks/CMCSA/) | $209.7M | 3,748,585 | 2.1% | 12 |
| UBER TECHNOLOGIES INC | [UBER](https://holderbook.com/stocks/UBER/) | $184.8M | 4,126,007 | 1.8% | 10 |
| PEGASYSTEMS INC | [PEGA](https://holderbook.com/stocks/PEGA/) | $156.0M | 1,227,701 | 1.5% | 12 |
| JOHNSON CONTROLS INTERNATION | [JCI](https://holderbook.com/stocks/JCI/) | $150.8M | 2,214,640 | 1.5% | 3 |
| OPTIMUM COMMUNICATIONS INC | [OPTU](https://holderbook.com/stocks/OPTU/) | $150.3M | 7,251,560 | 1.5% | 1 |
| META PLATFORMS INC | [META](https://holderbook.com/stocks/META/) | $145.5M | 428,790 | 1.4% | 3 |
| NERDY INC | [NRDY](https://holderbook.com/stocks/NRDY/) | $132.1M | 13,223,250 | 1.3% | 1 |
| MICROSOFT CORP | [MSFT](https://holderbook.com/stocks/MSFT/) | $131.3M | 465,660 | 1.3% | 3 |
| FIDELITY NATL FINL INC | [FNF](https://holderbook.com/stocks/FNF/) | $130.7M | 2,882,794 | 1.3% | 12 |
| VAXCYTE INC | [PCVX](https://holderbook.com/stocks/PCVX/) | $107.9M | 4,254,390 | 1.1% | 6 |
| ROSS STORES INC | [ROST](https://holderbook.com/stocks/ROST/) | $88.0M | 808,465 | 0.9% | 5 |
| TPG RE FIN TR INC | [TRTX](https://holderbook.com/stocks/TRTX/) | $87.7M | 7,086,779 | 0.9% | 12 |
| AMNEAL PHARMACEUTICALS INC | [AMRX](https://holderbook.com/stocks/AMRX/) | $86.6M | 16,213,367 | 0.9% | 12 |
| SONY GROUP CORP | [SONY](https://holderbook.com/stocks/SONY/) | $73.3M | 662,700 | 0.7% | 10 |
| KONINKLIJKE PHILIPS N V | [PHG](https://holderbook.com/stocks/PHG/) | $59.6M | 1,341,200 | 0.6% | 12 |
| MPLX LP | [MPLX](https://holderbook.com/stocks/MPLX/) | $58.9M | 2,069,650 | 0.6% | 12 |
| RALLYBIO CORP | [RLYB](https://holderbook.com/stocks/RLYB/) | $53.2M | 3,028,414 | 0.5% | 1 |
| DATTO HLDG CORP | [MSP](https://holderbook.com/stocks/MSP/) | $41.7M | 1,744,513 | 0.4% | 3 |
| BERRY GLOBAL GROUP INC | [BERY](https://holderbook.com/stocks/BERY/) | $31.7M | 521,290 | 0.3% | 10 |
| LIBERTY MEDIA CORP DEL | [FWONAXXXX](https://holderbook.com/stocks/FWONAXXXX/) | $29.7M | 632,179 | 0.3% | 5 |
| FUSION PHARMACEUTICALS INC | [FUSN](https://holderbook.com/stocks/FUSN/) | $20.2M | 2,551,794 | 0.2% | 6 |
| UXIN LTD | [UXIN](https://holderbook.com/stocks/UXIN/) | $18.5M | 6,710,950 | 0.2% | 2 |
| N-ABLE INC | [NABL](https://holderbook.com/stocks/NABL/) | $15.4M | 1,243,699 | 0.2% | 1 |
| GX ACQUISITION CORP II | [GXII](https://holderbook.com/stocks/GXII/) | $14.5M | 1,500,000 | 0.1% | 2 |
| DRAGONEER GROWTH OPT CORP II | [DGNU](https://holderbook.com/stocks/DGNU/) | $11.8M | 1,200,000 | 0.1% | 3 |
| SATSUMA PHARMACEUTICALS INC | [STSA](https://holderbook.com/stocks/STSA/) | $8.8M | 1,885,939 | 0.1% | 9 |
| AEYE INC | [LIDR](https://holderbook.com/stocks/LIDR/) | $8.2M | 1,500,000 | 0.1% | 1 |
| TREVI THERAPEUTICS INC | [TRVI](https://holderbook.com/stocks/TRVI/) | $6.8M | 4,824,883 | 0.1% | 10 |
| FLEXION THERAPEUTICS INC | [FLXN](https://holderbook.com/stocks/FLXN/) | $5.7M | 936,507 | 0.1% | 12 |
| HAMILTON LANE ALLIANCE HLDGS | [HLAH](https://holderbook.com/stocks/HLAH/) | $4.8M | 500,000 | 0.0% | 3 |
| ENTASIS THERAPEUTICS HLDGS I | [ETTX](https://holderbook.com/stocks/ETTX/) | $3.4M | 1,020,748 | 0.0% | 12 |
| FERGUSON PLC NEW | [FERGXXXX](https://holderbook.com/stocks/FERGXXXX/) | $2.6M | 18,949 | 0.0% | 2 |
| NERDY INC | [NRDYWS](https://holderbook.com/stocks/NRDYWS/) | $1.0M | 500,000 | 0.0% | 1 |
| RAPID MICRO BIOSYSTEMS INC | [RPID](https://holderbook.com/stocks/RPID/) | $885.0K | 47,935 | 0.0% | 1 |
| SANDBRIDGE X2 CORP | [SBIIWS](https://holderbook.com/stocks/SBIIWS/) | $400.0K | 500,000 | 0.0% | 2 |
| LIBERTY MEDIA ACQUISITION CO | [LMACW](https://holderbook.com/stocks/LMACW/) | $306.0K | 200,000 | 0.0% | 3 |
| GX ACQUISITION CORP II | [GXIIW](https://holderbook.com/stocks/GXIIW/) | $258.0K | 500,000 | 0.0% | 2 |
| HAMILTON LANE ALLIANCE HLDGS | [HLAHW](https://holderbook.com/stocks/HLAHW/) | $133.0K | 166,664 | 0.0% | 3 |
| ECP ENVIRONMENTAL GW OPT COR | [ENNVW](https://holderbook.com/stocks/ENNVW/) | $21.0K | 24,999 | 0.0% | 2 |
| FIGURE ACQUISITION CORP I | [FACAW](https://holderbook.com/stocks/FACAW/) | $20.0K | 18,750 | 0.0% | 2 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q3 2021 | -22.1% | +0.3% | -22.4% | 99% |
| Q2 2021 | +7.1% | +8.0% | -0.9% | 100% |
| Q1 2021 | -4.1% | +6.0% | -10.2% | 100% |
| Q4 2020 | +10.5% | +11.6% | -1.1% | 100% |
| Q3 2020 | +3.8% | +8.6% | -4.8% | 100% |
| Q2 2020 | +30.0% | +19.6% | +10.4% | 99% |
| Q1 2020 | -28.4% | -19.9% | -8.5% | 100% |
| Q4 2019 | +4.1% | +8.5% | -4.3% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q3 2021 | $10.1B | 52 |
| Q2 2021 | $14.0B | 79 |
| Q1 2021 | $8.6B | 65 |
| Q4 2020 | $9.0B | 39 |
| Q3 2020 | $5.6B | 39 |
| Q2 2020 | $5.7B | 36 |
| Q1 2020 | $4.3B | 35 |
| Q4 2019 | $6.8B | 44 |
| Q3 2019 | $13.5B | 51 |
| Q2 2019 | $6.6B | 51 |
| Q1 2019 | $5.1B | 48 |
| Q4 2018 | $6.2B | 53 |